Focus: Brussels: A little glimpse of ethics for the unionBMJ 1994; 308 doi: https://doi.org/10.1136/bmj.308.6945.1662 (Published 25 June 1994) Cite this as: BMJ 1994;308:1662
- R Watson
The business of ethics is not something one naturally associates with the European Union. The union conjures up images of political, economic, and social discussion, leaving intellectual debate on ethics to others. But that image is not entirely accurate: for the past two years a high powered group of advisers has been giving the European Commission the benefit of its collective wisdom on the ethical implications of biotechnology. It is now about to assume a much more public profile.
The guiding force behind the group's creation was Jacques Delors, the commission president. He signalled his intention in a speech at Strasbourg five years ago. As he said then: “The ethical dimension is once again coming to the fore, and we must step up the debate about these fundamental issues which concern the very essence of human life and society.” …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial